These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 15513340)

  • 1. Covered transjugular intrahepatic portosystemic stents maintain lower portal pressure and require fewer reinterventions than uncovered stents.
    Ockenga J; Kroencke TJ; Schuetz T; Plauth M; Kasim E; Petersein J; Schmidt HH; Lochs H
    Scand J Gastroenterol; 2004 Oct; 39(10):994-9. PubMed ID: 15513340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of transjugular intrahepatic portosystemic shunt dysfunction in PTFE-covered stent-grafts versus bare stents.
    Barrio J; Ripoll C; Bañares R; Echenagusia A; Catalina MV; Camúñez F; Simó G; Santos L
    Eur J Radiol; 2005 Jul; 55(1):120-4. PubMed ID: 15950109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uncovering the truth about covered stents: is there a difference between covered versus uncovered stents with transjugular intrahepatic portosystemic shunts?
    Clark W; Golkar F; Luberice K; Toomey P; Paul H; Marcadis A; Okpaleke C; Vice M; Hernandez J; Alsina A; Rosemurgy AS
    Am J Surg; 2011 Nov; 202(5):561-4. PubMed ID: 21944293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transjugular intrahepatic portosystemic stent-shunt: technical factors and new developments.
    Tripathi D; Redhead D
    Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1127-33. PubMed ID: 17033430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison study of Doppler ultrasound surveillance of expanded polytetrafluoroethylene-covered stent versus bare stent in transjugular intrahepatic portosystemic shunt.
    Huang Q; Wu X; Fan X; Cao J; Han J; Xu L; Li N
    J Clin Ultrasound; 2010 Sep; 38(7):353-60. PubMed ID: 20533444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is sonographic surveillance of polytetrafluoroethylene-covered transjugular intrahepatic portosystemic shunts (TIPS) necessary? A single centre experience comparing both types of stents.
    Pan JJ; Chen C; Geller B; Firpi R; Machicao VI; Caridi JG; Nelson DR; Morelli G
    Clin Radiol; 2008 Oct; 63(10):1142-8. PubMed ID: 18774362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoration of liver function and portosystemic pressure gradient after TIPSS and late TIPSS occlusion.
    Maedler U; Hansmann J; Duex M; Noeldge G; Sauer P; Richter GM
    Cardiovasc Intervent Radiol; 2002; 25(2):148-51. PubMed ID: 11901436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTFE-covered stents improve TIPS patency in Budd-Chiari syndrome.
    Hernández-Guerra M; Turnes J; Rubinstein P; Olliff S; Elias E; Bosch J; García-Pagán JC
    Hepatology; 2004 Nov; 40(5):1197-202. PubMed ID: 15486923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical results and hemodynamic changes of portal venous system in transjugular intrahepatic portosystemic stent shunt].
    Wu X; Cao J; Wu X
    Zhonghua Wai Ke Za Zhi; 1996 May; 34(5):303-6. PubMed ID: 9387710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The impact of secondary insertion of ePTFE-coated stent on sustainable TIPS patency].
    Jirkovský V; Fejfar T; Safka V; Hůlek P; Chovanec V; Krajina A; Raupach J; Lojík M
    Vnitr Lek; 2007 Feb; 53(2):123-8. PubMed ID: 17419172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanded polytetrafluoroethylene (ePTFE)-covered stents versus bare stents for transjugular intrahepatic portosystemic shunt in people with liver cirrhosis.
    Zhu P; Dong S; Sun P; Belgaumkar AP; Sun Y; Cheng X; Zheng Q; Li T
    Cochrane Database Syst Rev; 2023 Aug; 8(8):CD012358. PubMed ID: 37531575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival in patients undergoing transjugular intrahepatic portosystemic shunt: ePTFE-covered stentgrafts versus bare stents.
    Angermayr B; Cejna M; Koenig F; Karnel F; Hackl F; Gangl A; Peck-Radosavljevic M;
    Hepatology; 2003 Oct; 38(4):1043-50. PubMed ID: 14512892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of the secondary deployment of expanded polytetrafluoroethylene-covered stent grafts on maintenance of transjugular intrahepatic portosystemic shunt patency.
    Jirkovsky V; Fejfar T; Safka V; Hulek P; Krajina A; Chovanec V; Raupach J; Lojik M; Vanasek T; Renc O; Ali SM
    J Vasc Interv Radiol; 2011 Jan; 22(1):55-60. PubMed ID: 21106389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patency and clinical outcomes of transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stents versus bare stents: a meta-analysis.
    Yang Z; Han G; Wu Q; Ye X; Jin Z; Yin Z; Qi X; Bai M; Wu K; Fan D
    J Gastroenterol Hepatol; 2010 Nov; 25(11):1718-25. PubMed ID: 21039832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transjugular intrahepatic portosystemic shunt creation with the Viatorr expanded polytetrafluoroethylene-covered stent-graft.
    Hausegger KA; Karnel F; Georgieva B; Tauss J; Portugaller H; Deutschmann H; Berghold A
    J Vasc Interv Radiol; 2004 Mar; 15(3):239-48. PubMed ID: 15028808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved clinical outcome with transjugular intrahepatic portosystemic stent-shunt utilizing polytetrafluoroethylene-covered stents.
    Tripathi D; Ferguson J; Barkell H; Macbeth K; Ireland H; Redhead DN; Hayes PC
    Eur J Gastroenterol Hepatol; 2006 Mar; 18(3):225-32. PubMed ID: 16462534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanded polytetrafluoroethylene-covered stent-grafts for transjugular intrahepatic portosystemic shunts in cirrhotic patients: Long-term patency and clinical outcome results.
    Geeroms B; Laleman W; Laenen A; Heye S; Verslype C; van der Merwe S; Nevens F; Maleux G
    Eur Radiol; 2017 May; 27(5):1795-1803. PubMed ID: 27629421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The retrospective study of transjugular intrahepatic portosystemic shunt with covered or uncovered stents in patients with portal hypertension].
    Wu XJ; Cao JM; Han JM; Huang Q; Li N; Li JS
    Zhonghua Wai Ke Za Zhi; 2010 Jan; 48(2):83-7. PubMed ID: 20302722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenprocoumon for prevention of shunt occlusion after transjugular intrahepatic portosystemic stent shunt: a randomized trial.
    Sauer P; Theilmann L; Herrmann S; Bruckner T; Roeren T; Richter G; Stremmel W; Stiehl A
    Hepatology; 1996 Dec; 24(6):1433-6. PubMed ID: 8938176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case-control study of transjugular intrahepatic portosystemic stent shunts for patients admitted to intensive care following variceal bleeding.
    Corbett C; Murphy N; Olliff S; Mangat KS; Tripathi D
    Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):344-51. PubMed ID: 23354162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.